$33.37
Price
$1.1B
Market Cap
16.2
P/E Ratio
4.4
Forward P/E
$2.06
EPS (TTM)
—
Dividend Yield
$422M
Cash
$815M
Total Debt
32M
Shares Out
$28.73
$50.79
52-Week Range
Institutional Ownership of COLLEGIUM PHARMACEUTICAL INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Third Avenue Management|Matthew Fine
|
155.1K | $5M | $30.13 | +56.34% |
Trading Activity for COLLEGIUM PHARMACEUTICAL INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| SELL | -23.7% | 155.1K | $5M | $45.28 | |
| 2024-Q4 | |||||
| BUY | +11.4% | 203.4K | $6M | $31.33 | |
| 2024-Q3 | |||||
| BUY | +0.2% | 182.7K | $7M | $36.08 | |
| 2024-Q2 | |||||
| BUY | +68.6% | 182.3K | $6M | $34.25 | |
| 2024-Q1 | |||||
| BUY | +30.1% | 108.1K | $4M | $33.49 | |
| 2023-Q4 | |||||
| BUY | NEW | 83.1K | $3M | $25.11 | |
Insider Trading for COLLEGIUM PHARMACEUTICAL INC
6 Months Insider Sentiment
Buy $0
Sell $1.0M
0
Buys
3
Sells
-1.0M
Net
0
Grants
Largest
$533K
Dreyer
$315K
Dreyer
$280K
Dreyer
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 08, 2025 | Scott Dreyer | EVP & Chief Commercial Officer | EXERCISE | 17.6K | $15.90 | $280K |
| Dec 08, 2025 | Scott Dreyer | EVP & Chief Commercial Officer | SELL | 6.5K | $48.66 | $315K |
| Dec 08, 2025 | Scott Dreyer | EVP & Chief Commercial Officer | SELL | 11.1K | $47.89 | $533K |
| Dec 05, 2025 | Rita J. Balice-Gordon | Director | SELL | 3.6K | $47.03 | $172K |